| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 04/14/2005 | WO2005033056A2 Triphenylethylene compounds as selective estrogen receptor modulators |
| 04/14/2005 | WO2005032471A2 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 04/14/2005 | WO2004113391A3 Improved pharmaceutical drug candidates and methods for preparation thereof |
| 04/14/2005 | WO2003090678A3 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin |
| 04/14/2005 | US20050080271 Peptidomimetic ligands for cellular receptors and ion channels |
| 04/14/2005 | US20050080141 Amino diols useful in the treatment of alzheimer's disease |
| 04/14/2005 | US20050080119 Diaminopropionic acid derivatives |
| 04/14/2005 | US20050080099 Methods and kits for treating depression or preventing deterioration of cognitive function |
| 04/14/2005 | US20050080090 Such as 7-(Imidazolo[4,5-b]pyridin-1-yl)-1-(1-methylpyrrolidin-3-yl)naphthalene; for treating depression, anxiety, eating disorders, drug abuse, cluster headache, migraine, pain, and other disorders arising from deficient serotonergic neurotransmission |
| 04/14/2005 | US20050080088 Novel compounds |
| 04/14/2005 | US20050080077 Serotonin receptor antagonists such as cis-4,N-dimethyl-N-(3-(4-methylpiperidin-1-yl)cyclopentyl)-benzenesulfonamide for treatment of neurological conditions (depression and sleep disorders) |
| 04/14/2005 | US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators |
| 04/14/2005 | US20050080072 Such as 11-[4-[2-(2-hydroxyethoxy)ethyl]-1-pinerazinyl]dibenzo[b,f][1,4]thiazepine (quetiapine) via reduction, cyclization, and deprotection |
| 04/14/2005 | US20050080067 Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 04/14/2005 | CA2540826A1 Melanin concentrating hormone antagonists |
| 04/14/2005 | CA2540638A1 Quinoxaline compounds |
| 04/14/2005 | CA2540452A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 04/13/2005 | EP1521748A1 Novel anthracene derivatives and the use thereof as a medicament |
| 04/13/2005 | EP1521740A2 Probucol derivatives |
| 04/13/2005 | EP1521733A1 Modulators of the glucocorticoid receptor |
| 04/13/2005 | EP1077962B1 Isocyanate derivatizing agent and methods of production and use |
| 04/13/2005 | CN1606548A Aryloxyphenyl and arylsulfanylphenyl piperazine derivatives |
| 04/13/2005 | CN1606543A Alpha-cyanoacrylates |
| 04/13/2005 | CN1196680C Modulators of dopamine neurotransmission |
| 04/13/2005 | CN1196673C (-)-Verbenzone derivs. |
| 04/12/2005 | US6878736 Histamine H3 receptor ligands |
| 04/12/2005 | US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough |
| 04/12/2005 | US6878724 Polyarylcarboxamides useful as lipid lowering agents |
| 04/12/2005 | US6878712 E.g., (R)-((2S,5R)-2-methyl-5-methyl-4-(4-carboxyphenyl-sulphonyl)-1-(3,3,3 -trifluoro-2-hydroxy-2-methylpropionyl)-piperazine); antidiabetic agents |
| 04/12/2005 | US6878707 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion |
| 04/12/2005 | US6878706 N-(morpholinocarbonylmethyl)-N-isobutyl(benzylcarbonyl-N -cyanoamino)acetamide; treating rheumatoid arthritis, autoimmune diseases, osteoporosis, asthma, Alzheimer's disease, atherosclerosis and endometriosis. |
| 04/12/2005 | US6878700 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 04/12/2005 | CA2203936C Boronic ester and acid compounds, synthesis and uses |
| 04/12/2005 | CA2122571C Adhesion receptor antagonists |
| 04/07/2005 | WO2005030188A2 Phenyl-piperazine derivatives as modulators of muscarinic receptors |
| 04/07/2005 | WO2005030135A2 Nitrosated glutamic acid compounds, compositions and methods of use |
| 04/07/2005 | WO2005019147A3 Pesticidally active phenol derivatives |
| 04/07/2005 | WO2005014533A3 Aryl and heteroaryl compounds, compositions, and methods of use |
| 04/07/2005 | WO2005007076A3 Colchicine derivatives |
| 04/07/2005 | WO2005000845A3 Bicyclic derivatives as nk-1 and nk-2 antagonists |
| 04/07/2005 | WO2004110364A9 Thiotungstate analogues and uses thereof |
| 04/07/2005 | WO2003028728A8 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands |
| 04/07/2005 | US20050075392 cyclopentyl substituted glutaramide derivatives; inhibitors of neutral endopeptidase which may be used to treat cardiovascular disorders, especially hypertension |
| 04/07/2005 | US20050075381 a [4-(5-phenyl)oxazolyl]-N-acetyl pyrrolidine or a [1-amino-2-hydroxy-2-phenylethyl]-N-acetyl pyrrolidine; enzyme inhibitors; anticarcinogenic, antitumor agents |
| 04/07/2005 | US20050075374 Sulfonyl aryl or heteroaryl hydroxamic acid compounds |
| 04/07/2005 | US20050075368 Solvent extracting natural E2,E4-decadienal and undecadienal from ground, dried fruit of piper species; oxidation, esterification and transamidation; taste and aroma enhancers; bactercidel, fungicide and insecticidide activity |
| 04/07/2005 | US20050075367 Ester compound and medicinal use thereof |
| 04/07/2005 | US20050075344 Melanocortin receptor agonists |
| 04/07/2005 | US20050075324 Melanin concentrating hormone antagonists |
| 04/07/2005 | US20050074533 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof |
| 04/07/2005 | CA2540186A1 Phenyl-piperazine derivatives as modulators of muscarinic receptors |
| 04/07/2005 | CA2539973A1 Nitrosated glutamic acid compounds, compositions and methods of use |
| 04/06/2005 | EP1520850A2 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof |
| 04/06/2005 | EP1519932A1 Bisarylsulfonamide compounds and their use in cancer therapy |
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/06/2005 | CN1604890A 取代的环己烷衍生物 Substituted cyclohexane derivatives |
| 04/06/2005 | CN1603291A Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 04/06/2005 | CN1195738C 2'-substd. 1, 1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds |
| 04/06/2005 | CN1195737C HIV proteinase inhibitor |
| 04/06/2005 | CN1195735C Sulfonylamino derivatives which inhibit matrix-degrading metallopr teinases |
| 04/05/2005 | US6875831 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers |
| 04/05/2005 | US6875780 Compounds that modulate PPAR activity and methods for their preparation |
| 04/05/2005 | US6875775 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 04/05/2005 | US6875765 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family |
| 04/05/2005 | US6875764 Urea and thiourea compounds useful for treatment of coccidiosis |
| 04/05/2005 | US6875760 Glucagon antagonists/inverse agonists |
| 04/05/2005 | US6875759 Anticancer agents; analgesics |
| 04/05/2005 | CA2245686C In situ block copolymer formation during polymerization of a vinyl aromatic monomer |
| 03/31/2005 | WO2005028459A1 Preparation method for quetiapine |
| 03/31/2005 | WO2005028458A1 Preparation of quetiapine |
| 03/31/2005 | WO2005028457A1 Preparation of quetiapine |
| 03/31/2005 | WO2005028427A1 Aminoalkylamide substituted cyclohexyl derivatives |
| 03/31/2005 | WO2005028426A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 03/31/2005 | WO2005028409A1 Alpha-hydroxy-benzeneacetic acid derivatives, and compounds having two 5-membered lactone rings fused to central cyclohexa-1,4-diene nucleus based upon the same, and uses of the compounds |
| 03/31/2005 | WO2005019193A3 Phenylurea derivatives useful in the treatment of conditions mediated by polo-like kinases (plk) |
| 03/31/2005 | WO2005005394A3 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 03/31/2005 | WO2004113270A3 Propionic acid derivatives useful in the treatment of lipid disorders |
| 03/31/2005 | WO2004098591A3 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases |
| 03/31/2005 | US20050070719 Central nervous system disorders; antidiabetic agents; antiinflammatory agents; antiarthritic agents;obesity; osteoporosis ; anticancer agents |
| 03/31/2005 | US20050070582 For example,1-{[2-(3,5-dimethylphenoxy)-5-nitrophenyl]sulfonyl}-4-ethylpiperazine or 1-{[2-(3,5-dichlorophenoxy)-5-nitrophenyl]sulfonyl}piperazine; for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders |
| 03/31/2005 | US20050070559 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3 |
| 03/31/2005 | US20050070539 Such as 1-(4-{4-[2-(cyclopropylmethyl-amino)-5-nitro-benzoyl]-piperazin-1-yl}-3-fluoro- phenyl)-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease |
| 03/31/2005 | US20050070527 For leukocyte recruitment inhibition, treating or preventing inflammation and H4 receptor-mediated conditions |
| 03/31/2005 | US20050070485 Phenylalanine derivatives |
| 03/31/2005 | US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response |
| 03/31/2005 | US20050066451 Para-phenylenediamine derivatives comprising a cyclic diaza group substituted with a cationic radical, and use of these derivatives for dyeing keratin fibers |
| 03/31/2005 | CA2539159A1 Aminoalkylamide substituted cyclohexyl derivatives |
| 03/31/2005 | CA2538866A1 Preparation of quetiapine |
| 03/31/2005 | CA2538745A1 Preparation of quetiapine |
| 03/30/2005 | EP1518553A2 Use of nitrate ester compounds for treating pain or providing analgesia |
| 03/30/2005 | EP1517900A1 Process for the production of n-(2,6-dimethyl-phenyl)-2-piperazin-1-yl-acetamide |
| 03/30/2005 | EP1517898A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases |
| 03/30/2005 | EP1517882A1 Amide linker peroxisome proliferator activated receptor modulators |
| 03/30/2005 | EP1517879A1 Aminoalkylphenols, methods of using and making the same |
| 03/30/2005 | EP1360184B1 Piperidine derivatives as neurokinin 1 antagonists |
| 03/30/2005 | EP1235831B1 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 03/30/2005 | EP1192127B1 Substituted benzamide inhibitors of rhinovirus 3c protease |
| 03/30/2005 | CN1602292A Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/29/2005 | US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents |